Nightmares and panic disorder associated with carvedilol overdose

Annals of Pharmacotherapy

Volumn 36, Issue 11, 2002, Pages 1736-1740

  Maebara, Chiharu ^a   Ohtani, Hisakazu ^a   Sugahara, Hideyo ^b   Mine, Kazunori ^a   Kubo, Chiharu ^b   Sawada, Yasufumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Carvedilol; Nightmares

Indexed keywords

CARVEDILOL; ETIZOLAM;

ADULT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CASE REPORT; DISEASE ASSOCIATION; DRUG OVERDOSE; EXPERIENCE; HUMAN; HYPERTENSION; MALE; NIGHTMARE; PANIC; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RECEPTOR BINDING; RECEPTOR OCCUPANCY; SLEEP DISORDER;

ADRENERGIC BETA-ANTAGONISTS; ADULT; CARBAZOLES; DREAMS; HUMANS; MALE; OVERDOSE; PANIC DISORDER; PREDICTIVE VALUE OF TESTS; PROPANOLAMINES;

EID: 0036841584     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A476     Document Type: Article

References (28)

1. Betts TA, Alford C. β-Blocking drugs and sleep: A controlled trial. Drugs 1983;25(suppl 2):268-72.
2. Betts TA, Alford C. β-Blockers and sleep: A controlled trial. Eur J Clin Pharmacol 1985;28(suppl):65-8.
3. Betts TA, Alford C, β-Blocking drugs and sleep: A controlled trial. Primary Cardiol Suppl 1983;1:201-5.
4. Koella WP. β-Blockers and CNS side-effects: CNS-related (side-) effects of β-blockers with special reference to mechanisms of action. Eur J Clin Pharmacol 1985;28(suppl):55-63.
5. Kositis JB, Rosen RC. Central nervous system effects of βadrenergic-blocking drugs: The role of ancillary properties. Circulation 1987;75:204-12.
6. Kositis JB, Rosen RC. Beta-blocker effects on central nervous system: A controlled comparative study (abstract). J Am Coll Cardiol 1986;7:25A.
7. Dahlof C, Dimenas E. Side effects of beta-blocker treatments as related to the central nervous system. Am J Med Sci 1990;299:236-44.
8. Shaw J, England JD. Nightmares, asthma and pindolol. Med J Aust 1977;2(2 suppl):12-4.
9. van den Brink G, Boer P, van Asten P, Dorhout Mees EJ, Geyskes GG. One and three doses of propranolol a day in hypertension. Clin Pharmacol Ther 1980;27:9-15.
10. Westerlund A. Central nervous system side-effects with hydrophilic and lipophilic beta-blockers. Eur J Clin Pharmacol 1985;28 (suppl):73-6.
11. Yamada Y. Shibuya F, Hamada J, Sawada Y, Iga I. Prediction of sleep disorders induced by beta-adrenergic receptor blocking agents based on receptor occupancy. J Pharmacokinet Biopharm 1995;23:131-45.
12. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
13. Yamada Y. Ito K, Nakamura K, Sawada Y, Iga T. Prediction of therapeutic doses of beta-adrenergic receptor blocking agents based on quantitative structure pharmacokinetic/pharmacodynamic relationship. Biol Pharm Bull 1993;16:1251-9.
14. Fujimaki M, Hakusui H, Hasegawa Y, Ajima H, Ota H, Igarashi S, et al. Pharmacokinetics of carvedilol (DQ-2466) in healthy subjects. Jpn J Clin Pharmacol Ther 1990;21:415-24.
15. Interview Form of Carvedilol. Tokyo: Daiichi Pharmaceutical Co., May 2000.
16. Neil-Dwyer G, Bartlett J, McAinsh J, Cruickshank JM. Beta-adrenoceptor blockers and the blood-brain barrier. Br J Clin Pharmacol 1981;11: 549-53.
17. Thiessen BQ, Wallace SM, Blackburn JL, Wilson TM, Bergman U. Increased prescribing of antidepressants subsequent to β-blocker therapy. Arch Intern Med 1990;150:2286-90.
18. Hakusen H, Fujimaki M, Esumi Y, Takaichi M, Saitou T, Ootsuki M, et al. Studies on the metabolic fate of carvedilol (1). Pharmacokinetics in rat following a single oral dose. Xenobio Metab Dispos 1989;4:637-49.
19. Ruffolo RR Jr, Gellai M, Hieble JP, Willette RN, Nichols AJ. The pharmacology of carvedilol. Eur J Clin Pharmacol 1990;38(suppl 2):S82-8.
20. Product Information. Carvisken (Pindolol). Tokyo: Novartis Pharma, October 2000.
21. Product Information. Inderal (Propranotol). Tokyo: AstraZeneca, December 2000.
22. Product Information. Tenormin (Atenolol). Tokyo: AstraZeneca, December 2001.
23. Lader M. Dependence on benzodiazepines. J Clin Psychiatry 1983;44: 121-7.
24. Lader M, File S. The biological basis of benzodiazepine dependence. Psychol Med 1987;17:539-47.
25. Lader MH, Petursson H. Benzodiazepine derivatives - Side effects and dangers. Biol Psychiatry 1981;16:1195-201.
26. Ashton H. Benzodiazepine withdrawal: Outcome in 50 patients. Br J Addict 1987;82:665-71.
27. Schredl M, Kronenberg G, Nonnell P, Heuser I. Dream recall, nightmare frequency, and nocturnal panic attacks in patients with panic disorder. J Nerv Ment Dis 2001;189:559-62.
28. Rosenthal T, Rabinowitz B, Boichis H, Elazar E, Brauner A, Neufeld HN. Use of labetalol in hypertensive patients during discontinuation of clonidine therapy. Eur J Clin Pharmacol 1981;20:237-40.